Akre Capital Management — Profile of the Compounding Machine Builder
Akre Capital Management — Chuck Akre's legendary focus on compounding machines. Concentrated portfolio of exceptional businesses. Complete fund profile.
10 min czytaniaFact-checked against primary sources on · figures re-verified on regulator, issuer or SEC filings — not copied from other sites
Akre Capital Management — The Art of Compounding
Akre Capital Management is a quality-focused investment firm built around one powerful idea: finding compounding machines — businesses that can compound capital at high rates for decades. Founded by Chuck Akre, one of America's most respected but least famous great investors, the firm manages roughly $6.7 billion (mid-2026, after years of post-succession outflows).
Quick Answer
Akre Capital Management is a Middleburg, Virginia quality-focused investment firm founded in 1989 by Chuck Akre, built around hunting for compounding machines that reinvest profits at high returns for decades. It runs a deliberately concentrated portfolio of ~20-25 holdings with very low turnover, selected through Akre's "three-legged stool" framework: extraordinary business, talented owner-minded management, and great reinvestment opportunities. Holdings tilt toward asset-light, high-ROIC, recurring-revenue names — the Q2 2026 13F ($5.1B, 20 positions) is led by Mastercard (~20%), Moody's, Brookfield, KKR and Fair Isaac — accessible via the Akre Focus ETF (AKRE), which the Akre Focus Fund (AKREX) converted into in October 2025 in one of the industry's largest mutual-fund-to-ETF conversions. 13F holdings are public, lagged filings, useful as a signal of institutional positioning, not investment advice.
Key Facts
| Parameter | Value |
|---|---|
| Founder | Chuck Akre |
| Style | Quality compounders, concentrated |
| AUM | ~$6.7 billion (July 2026) |
| 13F portfolio (Q2 2026) | ~$5.1B across 20 positions |
| Headquarters | Middleburg, Virginia, USA |
| Founded | 1989 |
| Flagship Fund | Akre Focus ETF (AKRE) — converted from mutual fund AKREX in Oct 2025 |
| Holdings | ~20-25 stocks |
| Key Concept | "Three-legged stool" |
Investment Philosophy
Akre's philosophy revolves around the "three-legged stool" framework:
Leg 1: Extraordinary Business
- High returns on capital
- Large and growing addressable market
- Strong competitive moat
Leg 2: Talented Management
- Operators who think like owners
- Proven capital allocation track record
- Aligned incentives (skin in the game)
Leg 3: Great Reinvestment Opportunities
- The company can reinvest profits at high returns
- This is the compounding engine — profits that generate more profits
- Runway for decades of growth
All three legs must be present. If any is missing, it's a pass.
Savings in one bank, investments in another? See it all in one place — and how many months it could carry you.
See your Freedom Runway — freeKey People
- Chuck Akre — Founder. Spent 50+ years in investing. Known for patience, humility, and obsession with compounding. Stepped back from day-to-day management but remains Chairman.
- John Neff — CEO, CIO and sole portfolio manager since 2024. Akre's chosen successor.
- Andrew Millette and Trey Tickner — analysts who bought ownership stakes in the firm in January 2025 (former co-CIO Chris Cerrone left in 2023).
Portfolio Characteristics
| Trait | Detail |
|---|---|
| Concentration | ~20-25 holdings |
| Turnover | Very low (~10-15% annually) |
| Holding period | 5-10+ years |
| Style | Quality growth compounders |
| Typical companies | Asset-light, high ROIC, recurring revenue |
Why Track Akre Capital?
Chuck Akre has compounded capital at ~15%+ annually for decades — putting him in the same league as Buffett over comparable periods. His focus on compounding machines means when Akre buys something, they expect to hold it for many years.
What you can learn:
- Compounding is king — the #1 factor in long-term wealth creation
- Quality over quantity — 20 great businesses beat 200 mediocre ones
- Patience — let your winners run for years, not months
- The three-legged stool — a simple but powerful framework for stock selection
Track Akre's compounding machines with Freenance and see how quality-focused investing impacts your Financial Freedom Runway.
FAQ
What is a "compounding machine"?
A compounding machine is a business that can reinvest its profits at high returns on capital for many years. Think of it as compound interest applied to a business — profits generate more profits, which generate even more. Akre looks for companies that can do this for 10-20+ years.
How does Akre Focus Fund perform?
The Akre Focus strategy (now the AKRE ETF, formerly the AKREX mutual fund) significantly outperformed the S&P 500 over its first decade, with particularly strong performance during long bull markets. The concentrated approach means higher volatility in downturns but greater upside in recoveries.
What types of companies does Akre own?
Akre favors asset-light businesses with high returns on invested capital, recurring revenue, and strong competitive positions. Historically, the portfolio has included names in payments, financial exchanges, real estate, and software — businesses with powerful compounding characteristics.
How much does Akre Capital Management manage?
Akre Capital Management manages roughly $6.7 billion as of mid-2026 — down from a ~$15B+ peak, as assets flowed out after Chuck Akre's step-back. Most of this is concentrated in a small number of holdings reflecting the firm's high-conviction style. Worth checking the firm's current 13F disclosures for the latest reported equity book.
Who runs Akre Capital after Chuck Akre stepped back?
Chuck Akre transitioned day-to-day portfolio management while remaining Chairman. After co-CIO Chris Cerrone's 2023 departure, John Neff became CEO, CIO and sole portfolio manager, having worked alongside Akre for years to absorb the "three-legged stool" framework; analysts Andrew Millette and Trey Tickner took ownership stakes in early 2025.
Can retail investors invest alongside Akre Capital?
Retail investors generally cannot access the firm's private vehicles directly, but the publicly traded Akre Focus ETF (AKRE — converted from the AKREX mutual fund in October 2025) offers exposure to the same concentrated quality-compounder approach. As with any fund, it is worth reviewing current fees, holdings, and prospectus disclosures before drawing conclusions. This information is educational and not investment advice.